Skip to main content
Premium Trial:

Request an Annual Quote

Shoreline Biome Strikes Nordic Distribution Deal with AH Diagnostics

NEW YORK — Shoreline Biome said on Friday that it has signed an exclusive distribution deal for its microbiome research products in certain Nordic countries with AH Diagnostics.

Shoreline offers all-in-one microbiome assay kits, as well as related analysis software, designed to work on long-read Pacific Biosciences and Oxford Nanopore sequencing platforms and Illumina's short-read sequencing platform.

Under the terms of the deal, Denmark-based AH will distribute Shoreline's products in Denmark, Iceland, Sweden, Finland, and Norway. Additional terms were not disclosed.

Last month, Farmington, Connecticut-based Shoreline inked a distribution deal covering sub-Saharan Africa with Inqaba Biotechnical Industries.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.